A4L Announces IBM Innovation Space Participation

TORONTO, ON – Sep. 22, 2016 – Yesterday at a gathering of IBM executives and Ontario government officials, Analytics 4 Life (A4L), a Toronto-based eHealth company, announced its participation in the new and first IBM Innovation Space. Earlier this year, the Ontario government partnering with the Ontario Centres of Excellence (OCE) and IBM committed $54 million to support the creation of innovation hubs across Ontario to help small- and medium-sized businesses fast-track the introduction of new technologies and global expansion.

As a flagship company in the program, A4L was one of the first ventures to occupy space in the Toronto-based technology centre. The new office space provides access to technical resources, including IBM Cloud, IBM Watson cognitive business technology, IBM SoftLayer, and the IBM Bluemix cloud development platform. This collaboration equips A4L with secure and scalable cloud infrastructure to support its machine intelligence platform, Agilytics™.

Founded in Kingston, ON, privately-funded A4L now has offices in Toronto and the Research Triangle Park in North Carolina. “A few years ago, a small group of scientists at A4L realized that by applying machine learning to the signals naturally generated by the body, they could identify disease states,” says Ian Shadforth, A4L’s Chief Technology Officer. “Now we are building cloud-based medical device products that leverage a world-class suite of IBM cloud services to rapidly achieve our product development goals.”

In May 2016, the company launched its multi-center Coronary Artery Disease Learning and Algorithm Development (CADLAD) clinical study that will enroll up to 2,500 subjects from up to 25 medical centers within the United States. Chief Medical Officer, Dr. William Sanders, says, “A4L is currently testing a system that safely records patient signals and wirelessly transmits these files to secure cloud storage that allows powerful computer analytics to access and analyze billions of data points in real time.” He added, “CorVista™ is an investigational device and has not been approved for commercial distribution.”

The IBM Innovation Space was developed through Ontario’s Jobs and Prosperity Fund, which is expected to create up to 2,600 jobs and generate $410 million in follow-on investment.

About A4L
Analytics 4 Life (A4L) is a Toronto-based eHealth company using advanced phase signal processing techniques and machine learning for the purposes of identifying and assessing disease with its initial CorVista™ product focused on coronary artery disease (CAD). Beyond CAD, A4L has started to apply its machine intelligence platform, Agilytics™, to address other disease states in cardiology as well as neurology and oncology.


Analytics 4 Life
Jon Slebodnick

W2O pure
Christiana Pascale

SOURCE: PR Newswire